Advances in cancer immunotherapy

Specific engagement of immune effector functions is a rapidly advancing field within experimental tumor therapy. A recent meeting * * The 2nd International Dresden Symposium on Immunotherapy of Cancer was held at Dresden, Germany, on 12-13 June 1998. focused on the analysis of cellular and humoral i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Immunology today (Amsterdam. Regular ed.) 1999-02, Vol.20 (2), p.63-65
Hauptverfasser:	Ockert, Detlef, Schmitz, Marc, Hampl, Monika, Rieber, E.Peter
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antibodies, Monoclonal - immunology Antibodies, Monoclonal - therapeutic use Antibody therapy Antibody-Dependent Cell Cytotoxicity Antigens, Neoplasm - immunology Antitumor vaccination Chimera Clinical Trials as Topic Cytokines - genetics Dendritic cells Dendritic Cells - immunology Dendritic Cells - transplantation DNA, Complementary - genetics Dogs Genetic Therapy Graft vs Tumor Effect Humans Immunoconjugates - therapeutic use Immunotherapy - methods Immunotherapy - trends Immunotherapy, Adoptive Leukemia - therapy Lymphocyte Activation Lymphocyte Transfusion Neoplasms - therapy Salvage Therapy T-Lymphocytes, Cytotoxic - immunology Tumor therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Specific engagement of immune effector functions is a rapidly advancing field within experimental tumor therapy. A recent meeting * * The 2nd International Dresden Symposium on Immunotherapy of Cancer was held at Dresden, Germany, on 12-13 June 1998. focused on the analysis of cellular and humoral immune responses against tumors and on clinical trials of antitumor vaccination and antibody therapy.
ISSN:	0167-5699
DOI:	10.1016/S0167-5699(98)01388-7